Search
Clinician Ordering Portal
Frequently Asked Questions
Castle Biosciences works with all insurance providers, including Medicare, Medicaid, commercial insurers, and the VA, to secure payment for the DecisionDx-SCC test. Castle will submit insurance claims and manage the insurance billing process on behalf of patients. The company also sponsors an industry-leading Patient Assistance program with the belief that quality care should not depend on financial considerations. For more information about insurance coverage, claims processing and financial assistance call 866-788-9007 and select option #3.
Please call our customer service staff at 866-788-9007 or email.
DecisionDx-Melanoma provides you and your healthcare professional with personalized information to help inform decisions about your follow-up management and care plan. The test identifies the likelihood that your tumor could recur or spread within the next five years. For most patients eligible for a sentinel lymph node biopsy, the test can also provide information to help make decisions about this surgical procedure. This information should be helpful for you and your healthcare professional to decide on a treatment plan. Your care team will incorporate the DecisionDx-Melanoma results based on your individual situation, together with results from other tests and procedures.
Your healthcare professional (physician, physician assistant, or nurse practitioner) needs to order the test for you. The test can also be requested via an online portal.
The laboratory will send a report with the test results to your healthcare professional within approximately 5 days after receiving the tumor sample in our laboratory.